LabVoice Inc.
New Form D on file · 2025-04-01 · the record
Before you sell to, join or invest in LabVoice Inc.
MentionFox check on LabVoice Inc.: only 2 sources on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/labvoice-inc-form-d-25000001
Check LabVoice Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about LabVoice Inc.?
Based on the records MentionFox holds for this company. No flag is not a clearance.
LabVoice Inc. filed an amended Form D with the Securities and Exchange Commission on 2025-04-01.
LabVoice Inc. filed an amended Form D notice of an exempt securities offering with the SEC on April 1, 2025. The filing reports $1.20M sold. Its industry group is Biotechnology. It names Frederic Bost (Executive Officer, Director), Mathew Hahn (Director), Judy Ohrn Hicks (Director) (SEC Form D/A, April 1, 2025).
Is this your company?
Sell to companies like LabVoice Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-04-01 · the record
Pitching, partnering or investing alongside them? See who really runs and owns LabVoice Inc.
Free to see. No signup.
More on the people and the money behind LabVoice Inc., from the filings we hold.
Biotechnology raises by companies based in North Carolina, filed in April 2025, largest first.
Get an email when LabVoice Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when LabVoice Inc. raises, hires or launches. No email unless you switch it on.
Watch LabVoice Inc. →Get the full cited report on LabVoice Inc.
What the filing shows about LabVoice Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on LabVoice Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives LabVoice Inc.'s address as 252 Sweet Bay Place, Carrboro, NC 27510.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for LabVoice Inc. →
Amended on 2026-06-23: the offering size changed from $1,000,000 to $1,200,000; the amount sold changed from $700,007 to $1,200,000. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
LabVoice Inc. is a registered filer with the SEC (CIK 1951025) and has filed since 2022-10-18. 3 filings are on record, the latest on 2026-06-23.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
LabVoice Inc.'s Form D of 2025-04-01 names Frederic Bost, Mathew Hahn and Judy Ohrn Hicks as its officers, directors or promoters.
Its new offerings report $3.70M sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Proceeds will be used for working capital, which may include normal compensation to executive officers.
Frederic Bost is named as Executive Officer and Director on the Form D that LabVoice Inc. filed with the SEC on 1 April 2025, one of 3 people that filing names.
Mathew Hahn is named as Director on the Form D that LabVoice Inc. filed with the SEC on 1 April 2025, one of 3 people that filing names.
Judy Ohrn Hicks is named as Director on the Form D that LabVoice Inc. filed with the SEC on 1 April 2025, one of 3 people that filing names.
3 people named on the filing — 1 holding an executive role and 2 as directors only.
Named as of the 2025-04-01 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about LabVoice Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on LabVoice Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on LabVoice Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist LabVoice Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind LabVoice Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for LabVoice Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

https://mentionfox.com/funding/labvoice-inc-form-d-25000001